Beta Interferon News and Research

RSS
Clinical trials during a pandemic – lessons from COVID-19

Clinical trials during a pandemic – lessons from COVID-19

SARS-CoV-2 UK variant may induce more inflammation, study suggests

SARS-CoV-2 UK variant may induce more inflammation, study suggests

NIH to conduct large trial for COVID-19 polyclonal antibody therapies

NIH to conduct large trial for COVID-19 polyclonal antibody therapies

Scientists seek Covid treatment answers in cheap, older drugs

Scientists seek Covid treatment answers in cheap, older drugs

Study: SARS-CoV-2 virus adopts new strategy to ensure its replication, spread

Study: SARS-CoV-2 virus adopts new strategy to ensure its replication, spread

Study tracks the mutation rate of SARS-Cov-2 virus

Study tracks the mutation rate of SARS-Cov-2 virus

Cardiovascular disease in COVID-19

Cardiovascular disease in COVID-19

Treating metastatic breast cancer with immunotherapy

Treating metastatic breast cancer with immunotherapy

UBC researchers uncover potential adverse reactions of common multiple sclerosis drug

UBC researchers uncover potential adverse reactions of common multiple sclerosis drug

Dimethyl fumarate offers no added benefits for adults with RRMS

Dimethyl fumarate offers no added benefits for adults with RRMS

Biogen Idec receives marketing authorization from EC for multiple sclerosis drug

Biogen Idec receives marketing authorization from EC for multiple sclerosis drug

IQWiG study finds no added benefit of teriflunomide

IQWiG study finds no added benefit of teriflunomide

Researchers identify immune cell protein that sets off body's initial response against viral infection

Researchers identify immune cell protein that sets off body's initial response against viral infection

Adrenocorticotropic hormone may help treat people with multiple sclerosis

Adrenocorticotropic hormone may help treat people with multiple sclerosis

Fingolimod offers minor added benefit for patients with RRMS

Fingolimod offers minor added benefit for patients with RRMS

High cost of multiple sclerosis drugs

High cost of multiple sclerosis drugs

Pharmacy costs for multiple sclerosis patients increase at a faster rate than medical costs

Pharmacy costs for multiple sclerosis patients increase at a faster rate than medical costs

Bolder BioTechnology receives $1.2 million in Qualifying Therapeutic Discovery Project Grants

Bolder BioTechnology receives $1.2 million in Qualifying Therapeutic Discovery Project Grants

Medicare disability recipient dies of brain tumor after having coverage interrupted

Medicare disability recipient dies of brain tumor after having coverage interrupted

GG genotype may increase severity of multiple sclerosis symptoms: Study

GG genotype may increase severity of multiple sclerosis symptoms: Study